Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | C/O Select Medical Corp 4714 Gettysburg Rd MECHANICSBURG PA 17055 |
Tel: | N/A |
Website: | https://www.selectmedical.com |
IR: | See website |
Key People | ||
Robert A. Ortenzio Executive Chairman of the Board, Co-Founder | Christopher S. Weigl Senior Vice President, Chief Accounting Officer, Controller | Thomas P. Mullin Co-President |
John A. Saich Co-President | David S. Chernow Chief Executive Officer | Rocco A. Ortenzio Vice Chairman of the Board, Co-Founder |
Michael F. Malatesta Chief Financial Officer, Executive Vice President | Brian R. Rusignuolo Executive Vice President, Chief Information Officer | Michael E. Tarvin Senior Executive Vice President, General Counsel, Secretary | Martin F. Jackson Senior Executive Vice President of Strategic Finance and Operations |
Business Overview |
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers. Its segments include critical illness recovery hospital, rehabilitation hospital, outpatient rehabilitation, and Concentra. The critical illness recovery hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. Its Concentra segment consists of occupational health centers that provide workers' compensation injury care, physical therapy, and consumer health services and onsite clinics located at employer worksites that deliver occupational health services. |
Financial Overview |
For the three months ended 31 March 2024, Select Medical Holdings Corp revenues increased 7% to $1.79B. Net income applicable to common stockholders increased 37% to $93.5M. Revenues reflect Critical Illness Recovery Hospital segment increase of 10% to $655.9M, Rehabilitation Hospital segment increase of 15% to $265.7M, Concentra segment increase of 2% to $467.6M. |
Employees: | 38,400 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $8,138M as of Mar 31, 2024 |
Annual revenue (TTM): | $6,788M as of Mar 31, 2024 |
EBITDA (TTM): | $807.77M as of Mar 31, 2024 |
Net annual income (TTM): | $259.99M as of Mar 31, 2024 |
Free cash flow (TTM): | $177.05M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $3,755M as of Mar 31, 2024 |
Shares outstanding: | 130,031,562 as of Apr 30, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |